» Articles » PMID: 35110278

DiGeorge Syndrome: Consider the Diagnosis

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2022 Feb 3
PMID 35110278
Authors
Affiliations
Soon will be listed here.
Abstract

DiGeorge syndrome (DGS) is caused by a chromosomal microdeletion at 22q11.2 that results in impaired development of the pharyngeal pouch system. Patients with DGS may have developmental abnormalities of craniofacial structures, parathyroid glands, thymus and cardiac outflow tract. Doctors have been routinely testing for DGS in newborns with conotruncal cardiac anomalies since the late 1990s; before then, however, they relied on complex diagnostic criteria and the disease was often missed. Adults born with conotruncal defects before the late 1990s may have undiagnosed DGS. We present one such case: a 35-year-old woman with a cardiac diagnosis of tetralogy of Fallot and unilateral absence of a pulmonary arter who was found to have DGS. Identifying DGS in adults is important both for disease management and genetic counselling. Our case emphasises the importance of screening for DGS in adults who were born with conotruncal cardiac abnormalities before widespread neonatal testing became common.

Citing Articles

Hypoparathyroidism: diagnosis, management and emerging therapies.

Khan S, Khan A Nat Rev Endocrinol. 2025; .

PMID: 39905273 DOI: 10.1038/s41574-024-01075-8.


Phenotype of patients with late diagnosis of 22q11 deletion: a review and retrospective study.

Loh M, Schildkraut T, Byrnes A, Gelfand N, Gugasyan L, Horton A Intern Med J. 2024; 54(12):2015-2026.

PMID: 39425634 PMC: 11610662. DOI: 10.1111/imj.16534.


Late maternal diagnosis of DiGeorge syndrome with congenital hypoparathyroidism following antenatal detection of the same 22q11.2 microdeletion syndrome in the fetus.

Liarakos A, Tran P, Rao R, Murthy N BMJ Case Rep. 2022; 15(5).

PMID: 35606033 PMC: 9125717. DOI: 10.1136/bcr-2022-250350.

References
1.
McDonald-McGinn D, Sullivan K, Marino B, Philip N, Swillen A, Vorstman J . 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2016; 1:15071. PMC: 4900471. DOI: 10.1038/nrdp.2015.71. View

2.
Stout K, Daniels C, Aboulhosn J, Bozkurt B, Broberg C, Colman J . 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018; 73(12):e81-e192. DOI: 10.1016/j.jacc.2018.08.1029. View

3.
Jyonouchi S, McDonald-McGinn D, Bale S, Zackai E, Sullivan K . CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics. 2009; 123(5):e871-7. PMC: 4098848. DOI: 10.1542/peds.2008-3400. View

4.
Alpman Durmaz A, Karaca E, Demkow U, Toruner G, Schoumans J, Cogulu O . Evolution of genetic techniques: past, present, and beyond. Biomed Res Int. 2015; 2015:461524. PMC: 4385642. DOI: 10.1155/2015/461524. View

5.
Murphy K, Jones L, Owen M . High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999; 56(10):940-5. DOI: 10.1001/archpsyc.56.10.940. View